Allergan expands Refresh eye treatment portfolio7 Oct 2019
A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.
Allergan has launched three new over-the-counter (OTC) Refresh Relieva products: Refresh Relieva; Refresh Relieva PF (preservative-free) multidose; and Refresh Relieva for Contacts.
This new line of artificial tear formulations available in preserved, preservative-free multidose, and a formula designed for contact lens wearers, are specially formulated to relieve discomfort due to eye dryness and to prevent further irritation. Refresh, a doctor recommended brand of artificial tears, continues to expand its portfolio by offering the only family of products in the US with carboxymethylcellulose (CMC), hyaluronic acid (HA, an inactive ingredient), glycerin, and HydroCell technology - Allergan's proprietary sodium chloride (NaCl) free, glycerin-based solution that enables hydration and maintains the volume of cells on the ocular surface.
"We are pleased to expand our robust artificial tear portfolio with Refresh Relieva products as we continue to exemplify our commitment to innovation in eye care. This brand-new line provides doctors and patients with three unique options to treat patients' individual needs when it comes to dry, irritated eyes and contact lens dryness," said Jag Dosanjh, Senior Vice President, Allergan US Eye Care. "With Refresh Relieva for Contacts, contact lens patients now have a new option. As the number one selling brand in preservative-free artificial tears, it was also important to us to introduce Refresh Relieva in a new, convenient preservative-free bottle. Now patients can enjoy the convenience of a multidose bottle with all the benefits of being preservative-free."
Over 26 million people in the US suffer from symptoms of eye dryness, including irritation, burning, dryness, and discomfort. Eye dryness can be caused by advanced age, contact lens wear, certain medications, other medical conditions, or environmental factors. Studies show Refresh Relieva products improve the symptoms of eye dryness in patients, with a low incidence of blur upon installation.
70% of patients reported no blur when Refresh Relieva and Refresh Relieva for Contacts was first applied.
"As eye dryness varies for each patient, I'm excited to have three new artificial tear treatment options since we know that one size doesn't fit all for patients," said Milton Hom, OD. "Different patients have different needs and Refresh Relieva provides the diversity to satisfy more patients. With a low-blur formula and HydroCell technology Refresh Relieva will be my preferred artificial tear."
Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD
21 Feb 2020
Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.Read more
The game is on for connected devices
20 Feb 2020
Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.Read more
Management healthcare consultancy opens new offices in New York and London
19 Feb 2020
The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients.Read more
CPhI South East Asia rescheduled for July 2020
18 Feb 2020
Event move ensures extra precautions and safety measures takenRead more
Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics
18 Feb 2020
Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant.Read more
Dr Reddy's to acquire Wockhardt divisions
18 Feb 2020
Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the companyRead more
Sartorius sharpens its brand focus
17 Feb 2020
The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.Read more
FDA success for MedPharm Centre of Excellence
14 Feb 2020
The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.Read more
Report predicts booming ASEAN generics export market for 2020
13 Feb 2020
The changing opportunities are attributed to rising GMP standards and increased regional harmonization.Read more
Partnership formed to deliver effective biopharma industry testing
12 Feb 2020
Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation